等待開盤 09-20 09:30:00 美东时间
+1.570
+0.66%
Insulet (NASDAQ:PODD) underwent analysis by 5 analysts in the last quarter, rev...
09-18 03:00
Piper Sandler analyst Matt O'Brien maintains Insulet (NASDAQ:PODD) with a Overweight and raises the price target from $230 to $285.
09-17 19:50
Paramount Global (NASDAQ:PARAA) had declared $0.05/share quarterly dividend, Payable Oct. 1; for shareholders of record Sept. 16; ex-div Sept. 16. See PARAA Dividend Scorecard, Yield Chart, & Dividend...
09-14 02:44
The Nasdaq 100 closed higher by over 400 points during Wednesday's session. Inv...
09-12 19:44
Insulet (PODD – Research Report), the Healthcare sector company, was revisited ...
09-10 17:59
Insulet's (NYSE:PODD) short percent of float has fallen 8.83% since its last re...
08-31 01:00
Insulet Shares up 2.7% Premarket After FDA Clears Expanded Use of Co's Insulin ...
08-27 20:36
In a report released today, Josh Jennings from TD Cowen maintained a Buy rating...
08-27 19:15
Insulet (NASDAQ:PODD) said it has received FDA clearance for its Omnipod 5 Automated Insulin Delivery, or AID, system for the treatment of type 2 diabetes in adults. The company said the clearance mak...
08-27 05:26
Piper Sandler analysts selected 20 stocks that are "bottom-fishing" ideas. These stocks have had technical grade rankings of 20 for at least the last trailing five weeks, but with this week’s ranking ...
08-20 23:56